Yarrow Bioscience, Inc. (YARW)

NASDAQ: YARW · Real-Time Price · USD

30.21

+1.36 (4.71%)

At close: Sep 4, 2026, 4:00 PM EDT

28.80

-1.41 (-4.67%)

After-hours: Sep 4, 2026, 7:30 PM EDT

Yarrow Bioscience Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025
Operating Income	-3.98	-3.98
Net Income	-283.98	-283.98
Earnings Per Share	-66.82	-66.82
EPS Growth	-	-

Cash & Debt

Fiscal Year	Current	FY 2025
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025
Net Cash (Debt)	99.99	99.99
Net Cash Growth	-	-
Net Cash Per Share	23.53	23.53
Cash & Investments	99.99	99.99

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025
Period Ending	Dec '25 Dec 31, 2025	Dec '25 Dec 31, 2025
Operating Cash Flow	0.56	0.56
Free Cash Flow	0.56	0.56
Free Cash Flow Growth	-	-